News

Trontinemab is one of a class of new medicines aimed at clearing amyloid plaques. The new findings from phase two trials ...
Phase 1 results demonstrate that SUL-238, a first-in-class, orally administered, mitochondria-directed drug candidate, is ...
Roche Holding AG plans to test whether an experimental medicine can prevent Alzheimer’s disease symptoms in high-risk people, ...
Researchers have found that a pair of drugs can not only slow down Alzheimer’s disease but actually reverse it and restore memory in mice.
UCSF researchers found the cancer drugs letrozole and irinotecan may reverse Alzheimer's effects, reducing tau protein clumps ...
(Reuters) -Swiss drugmaker Roche Holding plans to test whether an experimental medicine can prevent Alzheimer's disease ...
Acknowledging the limits of disease-modifying drugs like Leqembi and Kisunla, companies like Bristol Myers Squibb, Acadia, ...
A new Alzheimer’s drug has been hailed as a major breakthrough after clinical trials showed it could clear the harmful brain ...
Microglia, a type of brain immune cell, can gobble up amyloid beta protein, which clumps together into toxic aggregates ...
The harmful clumps of tau protein that build up in brains affected by Alzheimer's were reduced significantly, and the mice ...
Scientists at UCSF and Gladstone Institutes have identified cancer drugs that promise to reverse the changes that occur in ...
Swiss drugmaker Roche Holding plans to investigate whether an experimental medicine can delay or prevent Alzheimer's disease ...